Recruiting

Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring

This study evaluates the effectiveness of a breast ultrasound method for the diagnosis of breast cancer. Diagnostic procedures, such as breast ultrasound, may help find and diagnose breast cancer, and may help measure a patient's response to earlier treatment. The purpose of this research is to test the effectiveness of a new investigational breast ultrasound method to detect an abnormality in the breast, and assess response to breast cancer treatment.

ClinicalTrials.gov IDNCT04799535

PhaseNot Applicable

Enrollment550

SponsorMayo Clinic

Age18 Years

SexALL

I'm interested View official listing

Conditions studied

Breast Carcinoma, Breast Neoplasm

About this study

Interventions

Procedure: Ultrasound — Undergo breast ultrasound

Primary outcomes

Specificity of ultrasound in detection of breast cancer (Up to study completion, an average of 1 year)

Eligibility information

Inclusion Criteria: * AIM 1: Patient volunteers, ages \>= 18 with suspicious breast masses scheduled for breast biopsy, or at least two weeks or more after breast biopsy * AIM 2: Patient volunteers, ages \>= 18 who have biopsy proven breast cancer and are going under neoadjuvant chemotherapy and/or endocrine therapy had their baseline MRI and/or ultrasound Exclusion Criteria: * Patients with breast implants or any condition that does not allow proper use of ultrasound (US)

Study locations

Mayo Clinic in Rochester, Rochester, Minnesota 55905 United States

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-10-01.